Furthermore, the release of IFN-γ from PBMCs stimulated with both TLR2 ligands was almost abolished in AD patients, whereas no significant difference was observed in the release of TNF-α between AD patients and healthy individuals (Fig. 2). This evidence concerns the gene IFNG and Alzheimer disease.